818 related articles for article (PubMed ID: 16377396)
1. PTH and the risks for hip, vertebral, and pelvic fractures among patients on dialysis.
Danese MD; Kim J; Doan QV; Dylan M; Griffiths R; Chertow GM
Am J Kidney Dis; 2006 Jan; 47(1):149-56. PubMed ID: 16377396
[TBL] [Abstract][Full Text] [Related]
2. Fracture risk after parathyroidectomy among chronic hemodialysis patients.
Rudser KD; de Boer IH; Dooley A; Young B; Kestenbaum B
J Am Soc Nephrol; 2007 Aug; 18(8):2401-7. PubMed ID: 17634437
[TBL] [Abstract][Full Text] [Related]
3. Mineral metabolism, mortality, and morbidity in maintenance hemodialysis.
Block GA; Klassen PS; Lazarus JM; Ofsthun N; Lowrie EG; Chertow GM
J Am Soc Nephrol; 2004 Aug; 15(8):2208-18. PubMed ID: 15284307
[TBL] [Abstract][Full Text] [Related]
4. [Prevalence of vertebral fractures and aortic calcifications in hemodialysis patients: comparison with a population of the same age and sex].
Rodríguez García M; Gómez Alonso C; Naves Díaz M; Díaz López JB; Megido J; Gago E; Forascepi R; Cannata Andía JB
Nefrologia; 2003; 23 Suppl 2():106-11. PubMed ID: 12778865
[TBL] [Abstract][Full Text] [Related]
5. Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: the Dialysis Outcomes and Practice Patterns Study (DOPPS).
Tentori F; Blayney MJ; Albert JM; Gillespie BW; Kerr PG; Bommer J; Young EW; Akizawa T; Akiba T; Pisoni RL; Robinson BM; Port FK
Am J Kidney Dis; 2008 Sep; 52(3):519-30. PubMed ID: 18514987
[TBL] [Abstract][Full Text] [Related]
6. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
7. Increased risk of mortality associated with hip fracture in the dialysis population.
Mittalhenkle A; Gillen DL; Stehman-Breen CO
Am J Kidney Dis; 2004 Oct; 44(4):672-9. PubMed ID: 15384018
[TBL] [Abstract][Full Text] [Related]
8. Increased incidence of hip fractures in dialysis patients with low serum parathyroid hormone.
Coco M; Rush H
Am J Kidney Dis; 2000 Dec; 36(6):1115-21. PubMed ID: 11096034
[TBL] [Abstract][Full Text] [Related]
9. Plasma parathyroid hormone level and prevalent cardiovascular disease in CKD stages 3 and 4: an analysis from the Kidney Early Evaluation Program (KEEP).
Bhuriya R; Li S; Chen SC; McCullough PA; Bakris GL
Am J Kidney Dis; 2009 Apr; 53(4 Suppl 4):S3-10. PubMed ID: 19285609
[TBL] [Abstract][Full Text] [Related]
10. Factors modulating cytosolic calcium. Role in lipid metabolism and cardiovascular morbidity and mortality in peritoneal dialysis patients.
Gadallah MF; el-Shahawy M; Andrews G; Ibrahim M; Ramdeen G; Hanna D; Gorospe W; Morkos A; Abbassian M; Moles K
Adv Perit Dial; 2001; 17():29-36. PubMed ID: 11510292
[TBL] [Abstract][Full Text] [Related]
11. Disordered mineral metabolism is not a risk factor for loss of residual renal function in dialysis patients.
Noordzij M; Voormolen NM; Boeschoten EW; Dekker FW; Bos WJ; Krediet RT; Korevaar JC;
Nephrol Dial Transplant; 2009 May; 24(5):1580-7. PubMed ID: 19155531
[TBL] [Abstract][Full Text] [Related]
12. Long-term cost and effect on quality of life of osteoporosis-related fractures in Sweden.
Ström O; Borgstrom F; Zethraeus N; Johnell O; Lidgren L; Ponzer S; Svensson O; Abdon P; Ornstein E; Ceder L; Thorngren KG; Sernbo I; Jonsson B
Acta Orthop; 2008 Apr; 79(2):269-80. PubMed ID: 18484255
[TBL] [Abstract][Full Text] [Related]
13. Clinical epidemiology of parathyroidectomy in hemodialysis patients: the USRDS waves 1, 3, and 4 study.
Slinin Y; Foley RN; Collins AJ
Hemodial Int; 2007 Jan; 11(1):62-71. PubMed ID: 17257358
[TBL] [Abstract][Full Text] [Related]
14. Mineral metabolism and mortality in dialysis patients: a reassessment of the K/DOQI guideline.
Noordzij M; Korevaar JC; Dekker FW; Boeschoten EW; Bos WJ; Krediet RT; Bossuyt PM; Geskus RB;
Blood Purif; 2008; 26(3):231-7. PubMed ID: 18305386
[TBL] [Abstract][Full Text] [Related]
15. Serum fibroblast growth factor-23 (FGF-23) and fracture risk in elderly men.
Mirza MA; Karlsson MK; Mellström D; Orwoll E; Ohlsson C; Ljunggren O; Larsson TE
J Bone Miner Res; 2011 Apr; 26(4):857-64. PubMed ID: 20928885
[TBL] [Abstract][Full Text] [Related]
16. Parathyroid hormone, vitamin D, renal dysfunction, and cardiovascular disease: dependent or independent risk factors?
Anderson JL; Vanwoerkom RC; Horne BD; Bair TL; May HT; Lappé DL; Muhlestein JB
Am Heart J; 2011 Aug; 162(2):331-339.e2. PubMed ID: 21835295
[TBL] [Abstract][Full Text] [Related]
17. Endogenous hormones and the risk of hip and vertebral fractures among older women. Study of Osteoporotic Fractures Research Group.
Cummings SR; Browner WS; Bauer D; Stone K; Ensrud K; Jamal S; Ettinger B
N Engl J Med; 1998 Sep; 339(11):733-8. PubMed ID: 9731089
[TBL] [Abstract][Full Text] [Related]
18. Assessment of phosphorus and calcium metabolism and its clinical management in hemodialysis patients in the community of Valencia.
Maduell F; Gorriz JL; Pallardo LM; Pons R; Santiago C;
J Nephrol; 2005; 18(6):739-48. PubMed ID: 16358233
[TBL] [Abstract][Full Text] [Related]
19. Direct healthcare costs of hip, vertebral, and non-hip, non-vertebral fractures.
Shi N; Foley K; Lenhart G; Badamgarav E
Bone; 2009 Dec; 45(6):1084-90. PubMed ID: 19664735
[TBL] [Abstract][Full Text] [Related]
20. Third-generation parathyroid hormone assays and all-cause mortality in incident dialysis patients: the CHOICE study.
Melamed ML; Eustace JA; Plantinga LC; Jaar BG; Fink NE; Parekh RS; Coresh J; Yang Z; Cantor T; Powe NR
Nephrol Dial Transplant; 2008 May; 23(5):1650-8. PubMed ID: 18065788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
